Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
May 24, 2016
(1)
May 13, 2016
(1)
May 03, 2016
(1)
Decision
Transfer
(2)
Cancellation, transfer in part
(1)
Complainant
La Redoute SAS
(1)
F. Hoffmann-La Roche AG
(1)
BOEHRINGER Ingelheim Pharma GmbH & Co. KG
(1)
Respondent
Wuxi Yilian LLC / Wuxi Yilian LLC
(1)
Vladimir Kiskov
(1)
Tigran Mosisyan
(1)
Private Person / Kseniya S Dzhabbarova
(1)
Netfirms AB
(1)
Lu Cong Ping
(1)
Kseniya S Dzhabbarova
(1)
Kseniya Dzhabbarova
(1)
Kravtsov Alexander / Alexander Kravtsov
(1)
Konayem Temirtassova / Konayem Temirtassova
(1)
MORE
Panelist
Sebastian M.W. Hughes
(1)
Mathias Lilleengen
(1)
Karen Fong
(1)
Complainant Country
Switzerland
(1)
Germany
(1)
France
(1)
Complainant Representative
Nameshield
(1)
Matkowsky Law P.C
(1)
CSC Digital Brand Services
(1)
Respondent Country
Sweden
(1)
Russia
(1)
China
(1)
Respondent Reply
No
(3)
RDNH Status
No
(3)
Case Language
English
(3)
Case Particular
D
(3)
Number Of Domains
1
(1)
3
(1)
11
(1)
Domain Extension
top
(3)
xyz
(1)
wang
(1)
space
(1)
review
(1)
org
(1)
nu
(1)
net
(1)
com
(1)
cc
(1)
MORE
Domain Extension Type
newgTLD
(3)
ccTLD
(2)
gTLD
(1)
Domain Length
7
(2)
8
(1)
9
(1)
10
(1)
12
(1)
13
(1)
15
(1)
17
(1)
19
(1)
Includes Hyphen
Yes
(1)
No
(3)
Includes Number
Yes
(1)
No
(3)
Includes Letter
Yes
(3)
Domain Registrar
Web Commerce Communications Limited dba WebNic.cc
(1)
Todaynic.com, Inc.
(1)
PDR Ltd. d/b/a PublicDomainRegistry.com
(1)
Mesh Digital Limited
(1)
GuangDong NaiSiNiKe Information Technology Co Ltd.
(1)
Gandi SAS
(1)
Chengdu West Dimension Digital Technology Co., Ltd.
(1)
Bizcn.com, Inc.
(1)
1API GmbH
(1)
3
cases found.
Decision Date: 2016-05
Domain Extension: top
Reset Search
spiriva.top
Transfer
WIPO D2016-0537
(Decision Date: May 24, 2016)
accutane-online.nu, accutane.space, accutane.top and 8 others...
Cancellation, transfer in part
WIPO D2016-0517
(Decision Date: May 13, 2016)
laredoute.cc, laredoute.top, laredoute.wang
Transfer
WIPO D2016-0481
(Decision Date: May 3, 2016)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll